iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Stock Short Interest Climbs 61.1%
by Mitch Edgeman · The Markets DailyiShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Free Report) was the target of a large growth in short interest in October. As of October 30th, there was short interest totaling 429,057 shares, a growth of 61.1% from the October 15th total of 266,270 shares. Based on an average daily trading volume, of 257,701 shares, the short-interest ratio is presently 1.7 days. Approximately 2.8% of the shares of the stock are sold short.
Hedge Funds Weigh In On iShares U.S. Pharmaceuticals ETF
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Allworth Financial LP increased its stake in iShares U.S. Pharmaceuticals ETF by 6.6% during the 3rd quarter. Allworth Financial LP now owns 1,589 shares of the company’s stock worth $157,000 after buying an additional 99 shares during the period. Sunbelt Securities Inc. boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 14.3% during the first quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock worth $83,000 after buying an additional 120 shares during the period. Bogart Wealth LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 392.2% during the 3rd quarter. Bogart Wealth LLC now owns 251 shares of the company’s stock worth $25,000 after buying an additional 200 shares in the last quarter. Russell Investments Group Ltd. lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 148.4% in the third quarter. Russell Investments Group Ltd. now owns 467 shares of the company’s stock valued at $47,000 after buying an additional 279 shares during the period. Finally, Balance Wealth Partners LLC bought a new stake in iShares U.S. Pharmaceuticals ETF during the third quarter worth approximately $42,000.
iShares U.S. Pharmaceuticals ETF Trading Down 1.3%
Shares of iShares U.S. Pharmaceuticals ETF stock traded down $1.39 during mid-day trading on Monday, hitting $109.64. 155,158 shares of the stock were exchanged, compared to its average volume of 177,916. The company has a 50-day simple moving average of $103.18 and a 200 day simple moving average of $95.97. iShares U.S. Pharmaceuticals ETF has a twelve month low of $80.25 and a twelve month high of $112.29. The stock has a market capitalization of $1.70 billion, a price-to-earnings ratio of 33.66 and a beta of 0.47.
About iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
Recommended Stories
- Five stocks we like better than iShares U.S. Pharmaceuticals ETF
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions